iBio shared results from a study in non-human primates through a GlobeNewswire release. The headline gives no figures, so tap through for the data.
Recap by typeshit. Full story at GlobeNewswire.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
Novo Nordisk shared the figure from a post-trial analysis of its next-generation experimental drug, with results broken out for women.
Patients moved off weekly Wegovy injections onto a daily pill, and Men's Journal reports one group's weight outcomes stood out from the rest.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
The model generates backbone shape, amino acid choice and side-chain packing together when designing peptides that bind a target pocket.
An Emory-linked abstract shown in Nashville found the link in past records. The authors say it isn't peer reviewed and patients shouldn't change medication over it.
Loading…